Boston Scientific Technical Analysis



As of date:4/17/2024
BSX stock price:67.96
BSX 50 DMA:67.08
BSX 200 DMA:57.38
BSX MACD (200-50):-9.70
BSX RSI:44.15
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)44.15
Extremely
Oversold

Also see:
BSX Market Cap History
BSX Shares Outstanding History
BSX YTD Return

Quotes delayed 20 minutes

Email EnvelopeFree BSX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Academy Sports & Outdoors Breaks Below 200-Day Moving Average - Notable for ASO
51 minutes ago


Triumph Financial Breaks Below 200-Day Moving Average - Notable for TFIN
52 minutes ago


Phreesia (PHR) Shares Cross Below 200 DMA
1 hour, 6 minutes ago


Hope Bancorp Shares Cross Below 200 DMA
1 hour, 10 minutes ago


TXN Crosses Below Key Moving Average Level
1 hour, 14 minutes ago


Monarch Casino & Resort (MCRI) Shares Cross Below 200 DMA
1 hour, 14 minutes ago


NSP Makes Bullish Cross Above Critical Moving Average
1 hour, 16 minutes ago


CVI Makes Notable Cross Below Critical Moving Average
1 hour, 21 minutes ago


SNA Crosses Below Key Moving Average Level
1 hour, 38 minutes ago


Waters (WAT) Shares Cross Below 200 DMA
1 hour, 40 minutes ago


FIVG Crosses Critical Technical Indicator
1 hour, 40 minutes ago


TMFG Getting Very Oversold
1 hour, 40 minutes ago


Bullish Two Hundred Day Moving Average Cross - FDP
1 hour, 41 minutes ago


MKC Makes Bullish Cross Above Critical Moving Average
1 hour, 44 minutes ago


ZYME Crosses Below Key Moving Average Level
19 hours, 54 minutes ago


More Technical Analysis News

BSX Technical AnalysisBSX RSI
Boston Scientific develops, manufactures and markets medical devices used in a range of interventional medical specialties. Co.'s MedSurg segment includes: Endoscopy, which develops and manufactures devices to diagnose and treat a range of gastrointestinal and pulmonary conditions; and Urology and Pelvic Health, which develops and manufactures devices to treat urological and pelvic conditions, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, incontinence and pelvic floor disorders. Co.'s Rhythm and Neuro segment develops and manufactures a range of implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.

When researching a stock like Boston Scientific, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from BSX Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for BSX stock — the real life supply and demand for the stock over time — and examines that data in different ways.
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
BSX DMABSX MACD
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Boston Scientific (BSX) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

CAH Technical Analysis
CI Technical Analysis
CNC Technical Analysis
COO Technical Analysis
COR Technical Analysis
CRL Technical Analysis
CTLT Technical Analysis
CVS Technical Analysis
DGX Technical Analysis
DHR Technical Analysis
More Healthcare companies »

 

Boston Scientific Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2024, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.